Summary
This study investigates the relationship between Type 2 (non-insulin-dependent) diabetes mellitus and hypercholesterolaemia with regard to delivery of cholesterol to cells and regulation of endogenous cholesterol synthesis. The ability of LDL, from hypercholesterolaemic and Type 2 diabetic patients, to suppress cellular cholesterologenesis and to enhance mitogen-stimulated lymphocyte proliferation was compared. Cholesterol synthesis was estimated by measuring [14C]-acetate incorporation into cholesterol and lymphocyte proliferation was assessed by [3H]-thymidine incorporation into mitogen-stimulated normal lymphocytes. The results indicate that LDL from both Type 2 diabetic patients in poor metabolic control and hypercholesterolaemic patients was significantly less effective (p < 0.001) than LDL from non-diabetic normocholesterolaemic subjects in suppressing cholesterol synthesis in lymphocytes. LDL from all hypercholesterolaemic patients enhanced lymphocyte proliferation to a greater extent than LDL from normocholesterolaemic subjects and this effect was significantly increased using LDL from Type 2 diabetic, hypercholesterolaemic patients. Both suppression of [14C]-acetate incorporation and enhancement of [3H]-thymidine uptake could be related to an increased esterified/free cholesterol ratio in the LDL particle. The fact that cholesterol synthesis and cell proliferation were markedly altered by the above changes in LDL composition suggests a mechanism for cellular cholesterol accumulation in the Type 2 diabetic patient, even in the absence of elevated serum cholesterol levels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bennion LT, Grundy S (1977) Effect of diabetes mellitus on cholesterol metabolism in man. N Engl J Med 296: 1365–1371
Sosenko JM, Breslow JL, Miettinen OS, Gabbay KH (1980) Hyperglycaemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med 302: 650–654
Goldstein JL, Brown MS (1977) The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46: 897–930
Cuthbert JA, Lipsky PE (1983) Immunoregulation by low density lipoprotein in man: low density lipoprotein inhibits mitogenstimulated human lymphocyte proliferation after initial activation. J Lipid Res 24: 1512–1524
Owens D, Collins P, Johnson A, Tomkin G (1988) Regulation of mitogen-induced lymphocyte transformation by low density lipoprotein. Biochem Soc Trans 16: 202–203
Jan-Kan Chen, Hoshi H, McClure DB, McKeehan WL (1986) Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J Cell Physiol 129: 207–214
Kim HK, Kurup IV (1982) Non-enzymatic glycosylation of human plasma low-density lipoprotein. Evidence for in vitro and in vivo glycosylation. Metabolism 31: 348–353
Steinbrecher UP, Witztum JL (1984) Glycosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33: 130–134
Chait A, Eisenberg S, Steinmetz A, Albers JJ, Bierman EL (1984) Low-density lipoproteins modified by lipid transfer protein have altered biological activity. Biochim Biophys Acta 795: 314–325
Hiramatsu K, Bierman EL, Chait A (1985) Metabolism of low-density lipoprotein from patients with diabetic hypertriglyceridaemia by cultured human skin fibroblasts. Diabetes 34: 8–14
Mahley RW, Innerarity TL, Pitas RE, Weisgraber KH, Brown JH, Gross E (1977) Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J Biol Chem 252: 7279–7287
Maher V, Devery RAM, Collins PB, Johnson AH, Tomkin GH (1987) Relationship between low density lipoprotein cholesterol and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in monocytes from Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 30: 553A (Abstract)
Havel RA, Eder HM, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Chapman MJ, Goldstein S, Lagrange D, Laplaud PM (1981) A density gradient, ultracentrifugal procedure for isolation of the major lipoprotein classes from human serum. J Lipid Res 22: 339–358
Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, Lagrange D (1988) Further resolution of the low density lipoprotein spectrum in normal human plasma: physiochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 29: 442–458
Naito HK, Wada M, Erhart LA, Lewis LA (1973) Polyacrylamide-gel disc-electrophoresis as a screening procedure for serum lipoprotein abnormalities. Clin Chem 19: 228–234
Markwell MAK, Haas SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206–210
Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MF (1987) Stimulation of cholesterol ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from Type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoprotein. Diabetologia 30: 916–923
Jack CM, Sheridan B, Kennedy L, Stout RW (1988) Non-enzymatic glycosylation of low-density lipoproteins. Results of an affinity chromatography method. Diabetologia 31: 126–128 (Letter)
Mistry P, Millar NE, Laker M, Hazzard WR, Lewis B (1981) Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. J Clin Invest 67: 493–502
Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest 97 [Suppl 21]: 77–89
Ho YK, Faust JR, Bilheimer DW, Brown MS, Goldstein JL (1977) Regulation of cholesterol synthesis by low density lipoprotein in isolated human lymphocytes. J Exp Med 145: 1531–1549
Cuthbert JA, Lipsky PE (1981) Sterol metabolism and lymphocyte responsiveness: inhibition of endogenous sterol synthesis prevents mitogen-induced human T cell proliferation. J Immunol 126: 2093–2099
Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL (1988) Glycosylation of low density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37: 550–557
Brown MS, Goldstein JL (1974) Familial hypercholesterolaemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci 71: 788–792
Tall A, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M (1987) Accelerated transfer of cholesterol esters in dyslipidaemic plasma: role of cholesteryl ester transfer protein. J Clin Invest 79: 1217–1225
Dullaart RPF, Groener JEM, Dikkeschei LD, Erkelens DW, Doorenbos H (1989) Increased cholesterylester transfer activity in complicated Type 1 (insulin-dependent) diabetes mellitus-its relationship with serum lipids. Diabetologia 32: 14–19
Zechner R, Dieplinger H, Roscher A, Krempler F, Kostner G (1982) The role of lecithin: cholesterol acyltransferase for the low density lipoprotein composition and specific binding to the B receptor. Biochem Biophys Acta 712: 433–435
Cuthbert JA, Lipsky PE (1989) Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes. Arteriosclerosis [Suppl 1] 9: 43–49
Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315–1321
Tall A (1986) Plasma lipid transfer proteins. J Lipid Res 27: 361–367
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Owens, D., Maher, V., Collins, P. et al. Cellular cholesterol regulation — A defect in the Type 2 (non-insulin-dependent) diabetic patient in poor metabolic control. Diabetologia 33, 93–99 (1990). https://doi.org/10.1007/BF00401046
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401046